Comparative study of hematological responses to platinum group metals, antimony and silver nanoparticles in animal models

Journal of Environmental Science and Health - Part A Toxic/Hazardous Substances and Environmental Engineering

Volumn 49, Issue 3, 2014, Pages 269-280

  Newkirk, Catherine E ^a   Gagnon, Zofia E ^a   Pavel Sizemore, Ioana E ^b  

^a MARIST COLLEGE   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Antimony; Hematology; Immune response; Palladium; Pathology; Platinum; Rhodium; Silver nanoparticles

Indexed keywords

COMPARATIVE STUDIES; HEMATOLOGY; IMMUNE RESPONSE; PLATINUM GROUP METALS; SILVER NANOPARTICLES; SILVER NANOPARTICLES (AGNPS); TOXICOLOGICAL EFFECTS; WHITE BLOOD CELLS;

ANTIMONY; ANTIMONY COMPOUNDS; BIOLOGY; BLOOD; HEAVY METALS; IMMUNE SYSTEM; NANOPARTICLES; PALLADIUM; PATHOLOGY; PLATINUM; RATS; RHODIUM;

SILVER;

ANTIMONY; PALLADIUM; PLATINUM; RHODIUM; SILVER NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD TOXICITY; CHICK EMBRYO; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYO; EMBRYOTOXICITY; FEMALE; HEAVY METAL POISONING; LEUKOCYTE; NONHUMAN; RAT; SPECIES DIFFERENCE; TOXICITY TESTING;

ANIMALS; ANTIMONY; CHICK EMBRYO; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LEUKOCYTE COUNT; LEUKOCYTES; LYMPH; METALS, HEAVY; NANOPARTICLES; PALLADIUM; PLATINUM; RATS; RATS, SPRAGUE-DAWLEY; RHODIUM; SILVER; SPECIES SPECIFICITY;

EID: 84889654442     PISSN: 10934529     EISSN: 15324117     Source Type: Journal    
DOI: 10.1080/10934529.2014.846589     Document Type: Article

References (49)

1. Campbell, T.W. Avian Hematology and Cytology; Iowa State Press: Ames, IA, 1995.
2. Diehl, D.B.; Gagnon, Z.E. Interactions between essential nutrients with platinum group metals in submerged aquatic and emergent plants. Water Air Soil Poll. 2007, 184, 255-267.
3. National Institute for Occupational Safety and Health (NIOSH). Documentation for Immediately Dangerous to Life or Health Concentrations (IDLHs), Chemical Listing and Documentation of Revised IDLH Values (as of 3/1/95), Centers for Disease Control and Prevention. Available at www.cdc.gov/niosh/idlh/intridl4.html (accessed July 2013).
4. Tillery, J.B.; Johnson, D.E. Determination of platinum, palladium, and lead in biological samples by atomic absorption spectrophotometry. Environ. Health Perspect. 1975, 12, 19-26.
5. Barbante, C.; Veysseyre, A.; Ferrari, C.; Van De Velde, K.; Morel, C.; Capodaglio, G.; Cescon, P.; Scarponi, G.; Boutron, C. Greenland snow evidence of large scale atmospheric contamination for platinum, palladium and rhodium. Environ. Sci. Technol. 2001, 35, 835-839.
6. Kummerer, K., ed. Emissions from Medical Care Units. In Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks; Springer: Berlin, 1996; 32-531.
7. Thornton, I.; Butler, D.; Docx, P.; Hession, M.; Makropoulos, C.; McMullen, M.; Nieuwenhuijsen, M.; Pitman, A.; Rautiu, R.; Sawyer, R.; Smith, S.; White, D.; Wilderer, P.; Paris, S.; Marani, D.; Braguglia, C.; Palerm, J. Pollutants in Urban Waste Water and Sewage Sludge; European Commission Directorate-General Environment: Luxembourg, 2001.
8. Hamelers, I.H.L.; can Loenen, E.; Staffhorst, R.W.H.M.; de Kruijff, B.; deKroon, A.I.P.M. Carboplatin nanocapsules: a highly cytotoxic, phospholipid-based formulation of carboplatin. Mol. Cancer Ther. 2006, 5, 2007-2012.
9. Kummerer, K. Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospital in relation to other sources-a review. Chemosphere 2001, 45, 957.
10. Dubiella-Jackowska, A., Polkowska, Z., Namiesnik, J. Platinum group metals: a challenge for environmental analytics. Pol. J. Environ. Stud. 2007, 16(3), 329-345.
11. Rauch, S.; Motelica-Heino, M.; Morrison, G.; Donard, F. Critical Assessment of platinum group element determination in road and urban sediments using ultrasonic nebulisation and high resolution ICP-MS. J. Anal. Atom. Spectrom. 2000, 15, 329-334.
12. Gagnon, Z.E.; Newkirk, C.E.; Hicks, S. Impact of platinum group metals on the environment: a toxicological, genotoxic and analytical chemistry study. J. Environ. Sci. Health Pt. A 2006, 41, 397-414.
13. International Programme on Chemical Safety. Environmental Health Criteria, 125: Platinum; World Health Organization Press: Geneva, Switzerland, 1991.
14. Wyllie, S.; Fairlamb, A.H. Differential toxicity of antimonial compounds and their effects on glutathione homeostasis in a human leukaemia monocyte cell line. Biochem Pharmacol. 2006, 7(3), 257-267.
15. Fowler, B.A.; Goering, P.L. In Metals and their Components in the Environment; Merian, E. Ed.; VCH: Weinheim, 1991, 743-758.
16. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Antimony and Compounds; U.S. Public Health Service: Atlanta, GA, 1992. Available at www.atsdr.cdc.gov/toxprofiles/tp.asp?id=332&tid=58 (accessed March 2013).
17. De Wolff, F.A. Antimony and health: incriminating stibine in the sudden infant death syndrome is difficult on current evidence. Br. Med. J. 1995, 310, 1216-1217.
18. Poon, R. Effects of potassium antimony tartrate on rat erythrocyte phosphofructokinase activity. J. Biochem. Mol. Toxicol. 1998, 12(4), 227-233.
19. Gagnon, Z.; Newkirk, C.; Pavel, I. Silver nanoparticle exposure: a hematological analysis of the immunological response in an avian model. In Metal Ions in Biology and Medicine and Aqueous Chemistry and Biochemistry of Silicon: vol. 11; Pele, L., Powell, J.J., Kinrade, S., Jugdaohsingh, R., Collery, Ph., Maymard, I., Badawi, A., Eds.; John Libbey Eurotext: Paris, 2011; 172-177.
20. Ying, J. Nanostructured Materials; Academic Press: New York, 2001.
21. Bothun, G.D. Hydrophobic silver nanoparticles trapped in lipid blazers: size distribution, bilayer phase behavior, and optical properties. J. Nanobiotechnol. 2008, 6, 13.
22. Hagfeldt, A.; Graetzel, M. Light-induced redox reactions in nanocrystalline systems. Chem. Rev. 1995, 95(1), 49-68.
23. Ahamed, M.; Karns, M.; Goodson, M.; Rowe, J.; Hussain, S.M.; Schlager, J.J.; Hong, Y. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol. Appl. Pharmacol. 2008, 233(3), 404-410.
24. Mnyusiwalla, A.; Daar, A.S.; Peter, A. Mind the gap: science and ethics in nanotechnology. Nanotechnology 2003, 14, R9-R13.
25. Sung, J.H.; Ji, J.H.; Yun, J.U.; Kim, D.S.; Song, M.Y.; Jeong, J.; Han, B.S.; Han, J.H.; Chung, Y.H.; Kim, J.; Kim, T.S.; Chang, H.K.; Lee, E.J.; Lee, J.H.; Yu, I.J. Lung function changes in Spraque-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal. Toxicol. 2008, 20(6), 567-574.
26. Kim, Y.S.; Kim, J.S.; Cho, H.S.; Rha, D.S.; Kim, J.M.; Park, J.D.; Choi, B.S.; Lim, R.; Chang, H.K.; Chung, Y.H.; Kwon, I.H.; Jeong, J.; Han, B.S.; Yu, I.J. Twenty-eight day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 2008, 20(6), 575-583.
27. Gundacker, C.; Hengstschlager, M. The role of the placenta in fetal exposure to heavy metals. Wien. Med. Wochenschr. 2012, 162(9-10), 201-206.
28. Goyer, R.A. Transplacental transport of lead. Environ. Health Perspect. 1990, 89, 101-105.
29. International Programme on Chemical Safety (IPCS). Chemical Safety Information from Intergovernmental Organizations. Available at www.inchem.org (accessed July 2013)
30. Moore, W. Jr.; Hysell, D.; Crocker, W.; Stara, J. Biological fate of 103Pd in rats following different routes of exposure. Environ. Res. 1974, 8, 234-240.
31. Moore, W.; Hysell, D.; Hall, L.; Campbell, K.; Stara, J. Preliminary studies on the toxicity and metabolism of palladium and platinum. Environ. Health Perspect. 1975, 10, 63-71.
32. Belyaeva, A.P. The effect produced by antimony on the generative function. Gig. Tr. Prof. Zabol. 1967, 11, 32-37.
33. Cann, M.C.; Zawidzka, Z.Z.; Airth, J.M.; Grice, H.C. The effect of ether anesthesia on plasma corticosteroids and hematologic responses. Can. J. Physiol. Pharmacol. 1965, 43(3), 463-468.
34. Animal Care and Use Committee of John Hopkins University. Survival Surgery Procedures: Rodents. John Hopkins University. Available at http://web.jhu.edu/animalcare/procedures/survivalrodents.shtml (accessed June 2013).
35. Bellairs, R.; Osmond, M. Atlas of Chick Development. Academic Press: San Diego, CA, 2005.
36. Creighton, J.A.; Eadon, D.G. Ultraviolet-visible absorption spectra of the colloidal spectra elements. J. Chem. Soc. Faraday Trans. 1991, 87(24), 3881-3892.
37. Trefry, J.C.; Monahan, J.L.; Weaver, K.M.; Meyerhoefer, A.J.; Markopoulos, M.M.; Arnold, Z.S.; Wooley, D.P.; Pavel, I.E. Size selection and concentration of silver nanoparticles by tangential flow ultrafiltration for SERS-based biosensors. J. Amer. Chem. Soc. 2010, 132, 10970-10972.
38. Jayabalan, J.; Singh, A.; Chari, C.; Srivastava, H.; Mukhopadhyay, P.K.; Srivastava, A.K.; Oak, S.M. Aggregated nanoplatelets: optical properties and optically induced disaggregation. J. Phys. Condens. Mat. 2008, 20(44), 8.
39. Leblanc, G. Acute toxicity. In A Textbook of Modern Toxicology, 3rd Ed.; Hodgson, E., Ed.; John Wiley & Sons, Inc: Hoboken, NJ, 2004; 215-224.
40. McKenzie, S.; Williams, J.L. The leukocyte, nonmalignant granulocyte and monocyte disorders, and nonmalignant lymphocyte disorders. In Clinical Laboratory Hematology, 2nd Ed.; Pearson: 2010; 104-145.
41. McKenzie, S.; Williams, J.L. The leukocyte, and nonmalignant granulocyte and monocyte disorders. In Clinical Laboratory Hematology, 2nd Ed.; Pearson Education, Inc.: Upper Saddle River, NJ, 2010; 383-403.
42. Sapolsky, R.M.; Romero, L.M.; Munck, A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 2000, Feb; 21(1), 55-89.
43. Brown, B. Hematopoiesis. In Hematology Principles and Procedures, 6th Ed.; Lippincott Williams and Wilkins: Philadelphia, PA, 1993; 35-82.
44. Andreasen, C.B.; Latimer, K.S.; Harmon, B.G.; Glisson, J.R.; Golden, J.M.; Brown, J. Heterophil function in healthy chickens with experimentally induced staphylococcal tenosynovitis. Vet. Pathol. 1991, Sept; 28(5), 419-527.
45. Tulub, A.A.; Stefanov, V.E. Cisplatin stops tubulin assembly into microtubules. A new insight into the mechanism of antitumor activity of platinum complexes. Inter. J. Biol. Macromol. 2001, 28(3), 191-198.
46. Shrivastava, A.; Shishodia, S.; Sodhi, A. Expression of LGA-1 adhesion molecules on cisplatin-treated macrophages. Biochim. Biophys. Acta (BBA)-Mol. Cell Res. 1998, 1402(3), 269-276.
47. Fumarulo, R.; Aresta, M. Cisplatin toxicity: effects on phagocyte functions. Inorg. Chim. Acta 1987, 137(1-2), 99-103.
48. Weirda, D.; Matamoros, M. Partial characterization of bone marrow hemopoiesis in mice after cisplatin administration. Toxicol. Appl. Pharmacol. 1984, 75(1), 25-34.
49. McKenzie, S.; Williams, J.L. The leukocyte, and nonmalignant lymphocyte disorders. In Clinical Laboratory Hematology, 2nd Ed.; Pearson Education, Inc., Upper Saddle River, NJ, 2010; 404-419.